We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Chest Imaging Software Offers Increased Clarity and Improved Nodule Detection

By HospiMedica International staff writers
Posted on 05 May 2010
New chest imaging technology suppresses ribs and clavicles on chest X-rays to produce a soft tissue image that increases clarity and improves the detection of lung nodules. More...


This technology utilizes existing X-ray equipment to provide a soft tissue image for digital chest X-rays. The software delivers no additional radiation dose to the patient and does not require any additional patient procedures or specialized equipment.

Riverain Medical (Dayton, OH, USA), an image enhancement and computer-aided detection company focused on providing physicians with tools to assist in image interpretation, announced that the U.S. Food and Drug Administration (FDA) has cleared the SoftView Enhanced chest imaging technology.

SoftView uses image processing and pattern recognition technologies to suppress bone in the chest X-ray. The resulting soft tissue image improves the visibility of tissue within the lung. Studies from the University of Chicago (IL, USA) revealed that using SoftView considerably improves the visibility of lung nodules and improves the radiologist's accuracy for detecting small (9 mm - 30 mm) lung cancers on chest radiographs without the need for specialized equipment or increased radiation dose to the patient.

"We found in two studies that SoftView can improve a radiologist's accuracy and sensitivity,” explained Dr. Heber MacMahon, radiologist and professor at the University of Chicago. "The technology makes lung nodules more conspicuous, especially when they're hiding behind ribs and clavicles and it achieves this without additional radiation dose to the patient or specialized equipment.”

"SoftView is now available in the United States, Europe, Canada, and Australia, and has gone through rigorous multireader, multicase studies to validate its effectiveness. We have conducted an impressive amount of analysis to get where we are today with this clearance,” remarked Diane Hirakawa, CEO and chairman of Riverain Medical. "We are excited to enter the U.S. market with a unique product that will offer significant clinical value to radiologists and their patients.”

Riverain Medical provides physicians with tools to assist them in image interpretation. With a focus on early detection, Riverain Medical continues research and development efforts to advance new and existing imaging technologies for a variety of clinical applications.

Related Links:
Riverain Medical




Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Patient Monitoring System
AlarmSense
Medical Adhesive
MED 5570U
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: 123RF

AI Platform Screens for Amyloid Cardiomyopathy Using ECG Images

Amyloid cardiomyopathy is a heart disease caused by deposits of misfolded proteins in the cardiac muscle. It is often missed until patients develop serious complications such as heart failure.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.